Philips CPAP Cancer Lawsuit News

Phillips Respironics Sleep Apnea Machine Recall Falls Far Short Of Expectations

Royal Phillips is now being called out onto the carpet by the Dutch government where they are headquartered to step up international recall efforts

Friday, June 3, 2022 - According to the US Food and Drug Administration (FDA), Phillips Respironics has been less than forthcoming in its efforts to replace the defective lines of sleep apnea machines that they were forced to recall. The US Department of Justice has gotten involved and pressured the FDA to insist that Phillips immediately step up their efforts to communicate with the device owners that to date have no idea when to expect a replacement device to arrive. It has been more than one year since the Phillips CPAP recall and patients have had to make other sleep enhancement arrangements. To confirm that Phillips is dragging their feet, the Dutch government in the Netherlands has stepped in to insist Phillips change their behavior and focus on implementing the recall. According to DutchNews.nl "Medical technology group, Philips has shown 'substantial and structural' shortcomings in its recall campaign for faulty sleep apnea technology, Dutch health service inspectors have told television current affairs show Nieuwsuur." DN tells readers that the Dutch government has reached out to the company to enhance their communications with their sleep apnea customers about the recall and the health risks customers face if they continue to use the necessary sleep device. "Philips also told Nieuwsuur that 70% of Dutch patients are still using the old machines,” according to DutchNews.nl. According to the report Phillips claims that it will have replaced 90% of the machines by the end of 2022, however, the company has a history of extending its self-imposed recall deadlines.

Phillips is accused of failing to take seriously the health implications that their machines are having on the over 3 million users in the United States. The Phillips line of sleep apnea machines is an essential medical device that millions of people from around the world rely on to be able to sleep well, or at all for that matter, at night. This is confirmed by Dutch lung specialist Monique Klaavar who told DutchNews, "Philips' communication with doctors and patients is 'deplorable'. 'We are talking about an essential medical aid here, not a vacuum cleaner,' she said." Hundreds of Phillip Sleep apnea lawsuits in the United States allege the device has caused chest pains, respiratory illnesses, lung cancer, and other types of Phillips CPAP cancer due to the user inhaling toxic particles, gasses, and chemicals through the machine's airway. Phillips is accused of procuring a sub-standard sound abatement foam material that can degrade if the user cleans the machine with unapproved Ozone cleaning solutions. Lawsuits have been filed against Phillips Respironics by users that have been sickened allegedly from using the devic and also by medical equipment suppliers whose reputations have been ruined by supplying the defective machine. Most Phillips sleep apnea devices have been prescribed by doctors that relied on the company's safety representations. Phillips is suing SoClean accusing its cleaning solution of causing or exacerbating the sound abatement foam malfunction.

More Recent Philips CPAP Cancer Lawsuit News:

Lawyers for CPAP Cancer Lawsuits

We will represent all persons in involved in a BiPAP or CPAP cancer lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who developed cancer or another serious side effect as a result of using a Philips CPAP sleep apnea machine or ventilator in --or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Philips BiPAP cancer lawyers serving will contact you promptly to discuss your case.



Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.